Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by Vanguard Group Inc.

Vanguard Group Inc. raised its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,812,611 shares of the company's stock after purchasing an additional 113,976 shares during the quarter. Vanguard Group Inc. owned 12.59% of Pediatrix Medical Group worth $141,861,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. State Street Corp raised its holdings in shares of Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after purchasing an additional 50,597 shares during the last quarter. Nordea Investment Management AB grew its position in Pediatrix Medical Group by 51.6% during the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company's stock worth $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC raised its stake in shares of Pediatrix Medical Group by 302.9% during the 3rd quarter. Barclays PLC now owns 142,087 shares of the company's stock valued at $1,646,000 after buying an additional 106,817 shares during the last quarter. Franklin Resources Inc. acquired a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at about $598,000. Finally, Principal Financial Group Inc. boosted its stake in shares of Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock worth $5,953,000 after buying an additional 63,581 shares during the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MD. Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price target for the company. Truist Financial lowered their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday. UBS Group lifted their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Finally, StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $16.75.

Pediatrix Medical Group Price Performance

MD stock traded down $0.21 during trading on Friday, hitting $13.35. The stock had a trading volume of 593,762 shares, compared to its average volume of 839,370. The company's 50-day moving average price is $14.33 and its two-hundred day moving average price is $13.91. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The stock has a market capitalization of $1.15 billion, a P/E ratio of -11.13, a PEG ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. As a group, research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.